Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Assessment of release kinetics, stability and polymer interaction of poloxamer 407-based thermosensitive gel of interleukin-1 receptor antagonist.

Akash MS, Rehman K, Sun H, Chen S.

Pharm Dev Technol. 2014 May;19(3):278-84. doi: 10.3109/10837450.2013.775158. Epub 2013 Mar 19.

PMID:
23506246
2.

Sustained delivery of IL-1Ra from pluronic F127-based thermosensitive gel prolongs its therapeutic potentials.

Akash MS, Rehman K, Li N, Gao JQ, Sun H, Chen S.

Pharm Res. 2012 Dec;29(12):3475-85. doi: 10.1007/s11095-012-0843-0. Epub 2012 Aug 21.

PMID:
22907416
3.

Evaluation of thermosensitive poloxamer 407 gel systems for the sustained release of estradiol in a fish model.

Cespi M, Bonacucina G, Pucciarelli S, Cocci P, Perinelli DR, Casettari L, Illum L, Palmieri GF, Palermo FA, Mosconi G.

Eur J Pharm Biopharm. 2014 Nov;88(3):954-61. doi: 10.1016/j.ejpb.2014.08.008. Epub 2014 Sep 4.

PMID:
25194925
4.

Sustained delivery of IL-1Ra from PF127-gel reduces hyperglycemia in diabetic GK-rats.

Akash MS, Rehman K, Sun H, Chen S.

PLoS One. 2013;8(2):e55925. doi: 10.1371/journal.pone.0055925. Epub 2013 Feb 8.

5.

Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.

Gupta H, Jain S, Mathur R, Mishra P, Mishra AK, Velpandian T.

Drug Deliv. 2007 Nov;14(8):507-15.

PMID:
18027180
6.

Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.

Djekic L, Krajisnik D, Martinovic M, Djordjevic D, Primorac M.

Int J Pharm. 2015 Jul 25;490(1-2):180-9. doi: 10.1016/j.ijpharm.2015.05.040. Epub 2015 May 19.

PMID:
26002567
7.

Influence of oleic acid on the rheology and in vitro release of lumiracoxib from poloxamer gels.

Moreira TS, de Sousa VP, Pierre MB.

J Pharm Pharm Sci. 2010;13(2):286-302.

8.

[Characteristics of poloxamer thermosensitive in situ gel of dexamethasone sodium phosphate].

Li XY, Zhu ZJ, Cheng AY.

Yao Xue Xue Bao. 2008 Feb;43(2):208-13. Chinese.

PMID:
18507351
9.

Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.

Gratieri T, Gelfuso GM, de Freitas O, Rocha EM, Lopez RF.

Eur J Pharm Biopharm. 2011 Oct;79(2):320-7. doi: 10.1016/j.ejpb.2011.05.006. Epub 2011 May 27.

PMID:
21641994
10.

Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.

Kojarunchitt T, Hook S, Rizwan S, Rades T, Baldursdottir S.

Int J Pharm. 2011 Apr 15;408(1-2):20-6. doi: 10.1016/j.ijpharm.2011.01.037. Epub 2011 Jan 25.

PMID:
21272624
11.

Stability evaluation of thermosensitive drug carrier systems based on Pluronic F-127 polymer.

Grela KP, Marciniak DM, Pluta J.

Acta Pol Pharm. 2014 Jan-Feb;71(1):167-80.

12.

Controlled release of morphine from a poloxamer 407 gel.

Jansen MM, Verzijl JM, Burger DM, Hekster YA.

Int J Pharm. 2013 Aug 16;452(1-2):266-9. doi: 10.1016/j.ijpharm.2013.05.032. Epub 2013 May 21.

PMID:
23707252
13.

Influence of additives on a thermosensitive hydrogel for buccal delivery of salbutamol: relation between micellization, gelation, mechanic and release properties.

Zeng N, Dumortier G, Maury M, Mignet N, Boudy V.

Int J Pharm. 2014 Jun 5;467(1-2):70-83. doi: 10.1016/j.ijpharm.2014.03.055. Epub 2014 Apr 1.

PMID:
24699353
14.

Liposomes interiorly thickened with thermosensitive nanogels as novel drug delivery systems.

Zhang B, Chen J, Lu Y, Qi J, Wu W.

Int J Pharm. 2013 Oct 15;455(1-2):276-84. doi: 10.1016/j.ijpharm.2013.07.020. Epub 2013 Jul 18.

PMID:
23872301
15.

Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties.

Liu Y, Zhu YY, Wei G, Lu WY.

Eur J Pharm Sci. 2009 Jun 28;37(3-4):306-12. doi: 10.1016/j.ejps.2009.02.022. Epub 2009 Mar 14.

PMID:
19491020
16.

In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.

He W, Guo X, Feng M, Mao N.

Int J Pharm. 2013 Dec 31;458(2):305-14.

PMID:
24409520
17.

Injectable thermally responsive mucoadhesive gel for sustained protein delivery.

Mayol L, Biondi M, Quaglia F, Fusco S, Borzacchiello A, Ambrosio L, La Rotonda MI.

Biomacromolecules. 2011 Jan 10;12(1):28-33. doi: 10.1021/bm1008958. Epub 2010 Dec 13.

PMID:
21142090
18.

In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide.

Erfani Jabarian L, Rouini MR, Atyabi F, Foroumadi A, Nassiri SM, Dinarvand R.

Eur J Pharm Sci. 2013 Jan 23;48(1-2):87-96. doi: 10.1016/j.ejps.2012.09.017. Epub 2012 Nov 3.

PMID:
23131800
19.

Modulation of the rheological and mucoadhesive properties of thermosensitive poloxamer-based hydrogels intended for the rectal administration of quinine.

Koffi AA, Agnely F, Ponchel G, Grossiord JL.

Eur J Pharm Sci. 2006 Mar;27(4):328-35. Epub 2005 Dec 13.

PMID:
16356700
20.

Sustained release of lidocaine from Poloxamer 407 gels.

Ricci EJ, Lunardi LO, Nanclares DM, Marchetti JM.

Int J Pharm. 2005 Jan 20;288(2):235-44. Epub 2004 Dec 8.

PMID:
15620863

Supplemental Content

Support Center